Skip to main content

Pierre Meulien

Pierre Meulien will step down as president and CEO of Genome Canada on July 17 to become the executive director of the Innovative Medicines Initiative in Belgium. Meulien has been with Genome Canada since October 2010. The organization has begun a global search for his successor. Cindy Bell, a member of Genome Canada's executive management team, will serve as its president and CEO on an interim basis.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.